V-01

V-01 is a protein subunit COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. __TOC__ == Preclinical studies ==

In the Vinony graph

Vinony's link graph records 1,278 inbound references to V-01, and connects out to phase of clinical research, vaccine and SARS-CoV-2.

Vinony files it under Chemical articles without CAS registry number, Chemical pages without ChemSpiderID and Chemical pages without DrugBank identifier.

Vinony links it to 6 Wikipedia language editions.

Wikidata facts

Show 1 more fact

vaccine for: COVID-19

via Wikidata · CC0

~1 min read

Encyclopedic overview

3 sections

Contents

Preclinical studies
Clinical studies
References

V-01 is a protein subunit COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. __TOC__ == Preclinical studies ==

A preclinical study in rhesus macaques was published in July 2021. The vaccine's ability to neutralize several variants of concern has also been tested in mice. Another study in mice tested V-01 as a booster after inactivated Covid vaccine, including neutralization of a range of variants of concern.

Excerpted from Wikipedia’s “V-01” article, available under the CC BY-SA 4.0 licence.